ArticleJournal of the Egyptian National Cancer Institute2026
Impact of bladder volume precision control on setup errors and dosimetry in intensity-modulated radiation therapy for cervical cancer.
Article in Journal of the Egyptian National Cancer Institute, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Interfractional variability and reproducibility of accumulated dose in cervical cancer radiotherapy associated with bladder volume.Radiological physics and technology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundCervical cancer is the most common gynecologic malignancy and a leading threat to women’s health. Intensity-modulated radiation therapy (IMRT) is a cornerstone treatment, but its success depends on precise patient positioning and consistent bladder distension to minimize setup errors and organ motion. This study evaluated the impact of bladder volume variation on setup errors during IMRT and the accuracy and clinical utility of a bladder volume scanner (BVS) for bladder volume management.
methodsWe conducted a prospective, allocated comparative study of 62 cervical cancer patients treated with IMRT between April 2021 and August 2022. Patients were allocated to a BVS group (n = 31) that used a bladder scanner to maintain a target bladder volume of 250–350 mL (± 30 mL) or to a control group (n = 31) that relied on a strong urge to urinate for bladder filling. We compared bladder volume consistency, setup errors in left-right (X), anterior-posterior (Y), and superior-inferior (Z) directions, homogeneity and conformity indices, and the volumes of bladder, rectum, and small intestine receiving 45 Gy between groups. We also analyzed the correlation between bladder volume measured by BVS and by computed tomography (CT).
resultsThe BVS group had significantly more consistent bladder volumes and significantly smaller setup errors in all directions than the control group. The median (interquartile range, IQR) setup errors in the BVS vs. control group were 1.0 (0.8–1.5) vs. 1.7 (1.2–2.5) mm in the X-axis, 0.4 (0.2–1.1) vs. 1.9 (1.5-3.0) mm in the Y-axis, and 1.1 (0.9–1.3) vs. 2.8 (2.0-3.5) mm in the Z-axis, respectively (all P < 0.01). The BVS group also showed improved dosimetry, with a better homogeneity index (1.01 vs. 1.11) and conformity index (0.98 vs. 0.94), and significantly lower bladder, rectum, and small intestine volumes receiving 45 Gy (24.6% vs. 29.1%, 19.7% vs. 25.3%, and 17.4% vs. 18.1%, respectively; all P < 0.01). Bladder volumes measured by the scanner were strongly correlated with CT-derived volumes (R = 0.977).
conclusionsPrecise bladder volume control using a BVS leads to more reproducible patient positioning, as evidenced by significantly reduced bony anatomy-based setup errors, and resulted in significantly reduced radiation exposure to adjacent organs. The strong correlation between BVS and CT measurements confirms the device’s reliability. By ensuring a reproducible daily anatomical setup, BVS-guided bladder management improves the precision of IMRT delivery. This approach mitigates a key source of treatment uncertainty and establishes a foundation for potentially safer margin reduction or dose escalation strategies in the future. The bladder scanner was highly accurate and reproducible, improving target delineation and potentially allowing safer dose escalation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.